Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers—Orchestra Project

Multimorbidity and Serological Response to SARS-CoV-2 Nine Months after 1st Vaccine Dose: European Cohort of Healthcare Workers—Orchestra Project

Understanding antibody persistence concerning multimorbidity is crucial for vaccination policies. Our goal is to assess the link between multimorbidity and serological response to SARS-CoV-2 nine months post-first vaccine. We analyzed Healthcare Workers (HCWs) from three cohorts from Italy, and one...

Full description

Bibliographic Details
Main Authors: Concepción Violán, Lucía A. Carrasco-Ribelles, Giulia Collatuzzo, Giorgia Ditano, Mahsa Abedini, Christian Janke, Christina Reinkemeyer, Le Thi Thu Giang, Filippo Liviero, Maria Luisa Scapellato, Marcella Mauro, Francesca Rui, Stefano Porru, Gianluca Spiteri, Maria Grazia Lourdes Monaco, Angela Carta, Marina Otelea, Agripina Rascu, Eleonóra Fabiánová, Zuzana Klöslová, Paolo Boffetta, Pere Torán-Monserrat
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Vaccines
Subjects:
SARS-CoV-2
antibodies
IgG
humoral immunity
seroprevalence
COVID-19
Online Access:https://www.mdpi.com/2076-393X/11/8/1340

Internet

https://www.mdpi.com/2076-393X/11/8/1340

Similar Items